nvax

Two weeks ago, Novavax (NVAX) shares soared some 10 percent after the small clinical-stage biotechnology company announced positive preclinical results for its new vaccine against H1N1 influenza. Shares jumped again today -- this time about 15 percent by late-afternoon trading -- after the vaccine...

Novavax (NVAX) shares soared some 10 percent today after the small clinical-stage biotechnology company announced positive preclinical results for its new vaccine H1N1 influenza, or swine flu. Novovax, based in Rockville, Maryland, developed the vaccine using proprietary virus-like particle (VLP)...